世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

次世代シーケンサー:新たな臨床応用と世界市場


Next-generation Sequencing: Emerging Clinical Applications and Global Markets

レポートの範囲 レポート対象範囲:臨床NGS技術、アプリケーション、産業、イニシアチブ、特許、企業。2020年、2021年、2022年、2023年、2028年のNGSベースの診断薬市場を示す。 本レポートでは、主なシー... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
BCC Research
BCCリサーチ
2024年1月22日 US$5,500
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
492 英語

 

サマリー

レポートの範囲

レポート対象範囲:臨床NGS技術、アプリケーション、産業、イニシアチブ、特許、企業。2020年、2021年、2022年、2023年、2028年のNGSベースの診断薬市場を示す。

本レポートでは、主なシーケンス技術をレビューし、遺伝子変異が臨床検査において重要である理由を説明しています。次に、臨床NGSアプリケーションに影響を与える重要な研究イニシアティブのいくつかを論じています。リキッドバイオプシーの形式についても論じています。主な市場促進要因についても論じています。

本レポートでは、検査の複雑性、臨床適応、検査目的別に市場を検証している。検査の複雑性とは、検査のプレックスレベル(すなわち、サンプル内で分析可能な遺伝子マーカーの数)とカバレッジ(例えば、ゲノムをカバーする範囲)を指す。検査の複雑さ別に市場を調査することで、どの製品(サンプル前処理、NGS装置、インフォマティクスなど)が将来的に需要が高まるかについての貴重な洞察が得られる。

本レポートでは、腫瘍学、心血管疾患、臨床微生物学/感染症、メンデル病、代謝/免疫疾患、神経疾患、生殖医療、移植医療など、特定のアプリケーション別のNGS診断薬の市場データと予測を提供しています。

特定の地理的市場、すなわち北米、欧州、アジア太平洋、その他の地域についても論じている。

分析した産業分野には、DNAシーケンス装置、ロングリードシーケンス、シーケンスインフォマティクス、ターゲット濃縮、CTCの捕捉と検出、リキッドバイオプシー、がんスクリーニング/早期発見、消費者直接検査、非侵襲的出生前検査などが含まれる。

本レポートでは、臨床NGS業界の100社以上を紹介しています。

またBCCリサーチは、主要な提携動向など、業界の最近の主要な買収や戦略的提携の概要も提供しています。

レポートには以下が含まれます:

- 41のデータ表および237の追加表
- 次世代シーケンサーの新たな臨床アプリケーションの世界市場の概要
- 2020年から2022年までの過去の収益データ、2023年の予測、2028年までの複合年間成長率(CAGR)の予測を含む世界市場動向の分析
- 疾患適応症、検査の複雑さ、検査目的、用途、地域別の市場シェア分析を伴う、現在の市場規模および収益成長見込みの評価
- 臨床NGS製品の市場機会、臨床用途、業界構造、規制シナリオ、NGSベースの診断および技術の使用に関する考察
- ゲノムマッピングプログラム、NGSプラットフォームの技術的進歩と革新、Thermo Fisher Scientific社のIon Torrent Genexus System、Agilent Technologies Inc社のMagnis NGS Prep Systemの解説
- 非侵襲的出生前検査(NIPT)や着床前遺伝学的検査(PGT)などのNGS指向の検査の説明とその利点についての考察
- 主要企業の市場シェア分析と独自技術、戦略的提携、その他の主要市場戦略、特許分析
- Illumina Inc.、Thermo Fisher Scientific Inc.、QIAGEN、Agilent Technologies Inc.、BGI Genomicsを含む主要企業のプロフィール

ページTOPに戻る


目次

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
What’s New in This Report?
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Overview
Introduction
Liquid and Tissue Biopsy
Clinical NGS Market
Growth Drivers of Clinical NGS
Key Trends
Industry
Chapter 4 Technology Background
Importance of DNA
Genetic Variation and Analysis
Genetic Analysis Technologies
Sequencing in Clinical Applications
Sequencing Technologies
History of DNA Sequencing
Sanger Sequencing Technology
NGS Platforms
Short-Read Platforms
Long-Read Platforms
Informatics Technologies
Base Calling
Mapping to a Reference Sequence
Variant Analysis
Artificial Intelligence Technologies
Clinical Sequencing Technology Challenges
Chapter 5 Clinical NGS Initiatives and Emerging Technologies
R&D Initiatives and Programs
1+ Million Genomes
Access to Treatment and Testing (ACTT)
Access to Comprehensive Genomic Profiling Coalition (ACGP)
Africa Pathogen Genomics Initiative
Blood Profiling Atlas
Cancer-ID
Cancer Moon Shots Program
China Precision Medicine Initiative
ClinGen
CTC Trap Consortium
diaRNAgnosis Project
Early Cancer Detection Consortium
EpiFemCare
France Genomic Medicine Plan
Friends of Cancer Research Project
Genomic Medicine Sweden
HCA-Organoid
Human Cell Atlas
Human Immunomics Initiative
Immunomonitor Consortium
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy Program
Intervene
Liquid Biopsies and Imaging for Improved Cancer Care
Liquid Biopsy-Based Malignant Tumor Early Screening Technology Research and Development Project
Liver Cancer Early Screening Comprehensive Prevention and Control Project
Lung Cancer Genomic Screening Project for Individualized Medicine in Asia
Million Veteran Program
Medical Genome Initiative
MedSeq
Precision Medicine Initiative
Prompt
QuIP Project
SPHERES
Target ALS Diagnosis Initiative
TopMed
Treehouse Childhood Cancer Initiative
Very Rare Cancer Consortium
Worldwide Innovative Networking (WIN) Consortium
Single-Cell Research
Cambridge Single-Cell Analysis Core Facility
Harvard Medical School Single-Cell Core
Mayo Medical Genome Facility
National Center for Single-Cell Biology
Next-Generation Single-Cell Analysis Program
Single-Cell Analysis Core
UC San Francisco Single-Cell Analysis Center
The Wistar Institute of Anatomy and Biology
Population Sequencing Projects
Chapter 6 Clinical NGS Applications
Introduction
Cancer Applications
Precision Medicine
Liquid Biopsy Biomarkers
Mendelian Disorders Applications
Reproductive Health Applications
Noninvasive Prenatal Testing
Newborn Screening
Microbiology and Infectious Disease Applications
Complex Disorders Applications
Chapter 7 Clinical NGS Industry
Sequencing Instrument Industry
Companies
Third-Generation Sequencing Industry
Sequencing Informatics Industry
Target Enrichment and Amplification Industry
CTC Capture and Detection Industry
Liquid Biopsy Assay Industry
Liquid Biopsy Cancer Screening/Early Detection Industry
Health-Focused DTC Genetic Testing Industry: Two Market Models
DTC Clinical Health Genetic Testing Industry
Noninvasive Prenatal Testing (NIPT) Industry
Chapter 8 ESG Development
Introduction to ESG
The Sustainability of NGS in Industry
Case Study
BCC Research Viewpoint
Chapter 9 Acquisitions and Strategic Alliances
Acquisitions
Strategic Alliances
Key Trends
Chapter 10 Clinical NGS Markets
Market Dynamics
Market Drivers
Impact of COVID-19 on the Clinical NGS Markets
Clinical NGS Market by Disease Category
Clinical NGS Market by Test Complexity
Clinical NGS Market by Purpose of Test
Clinical NGS Market in Oncology
Market by Indication in Oncology
NGS Market in Oncology by Purpose of Test
NGS Market in Oncology by Test Complexity
Clinical NGS Market in Cardiology
NGS Market in Cardiology by Purpose of Test
NGS Market in Cardiology by Test Complexity
Clinical NGS Market in Mendelian Disorders
NGS Market in Mendelian Disorders by Test Complexity
Clinical NGS Market in Metabolic/Immune Disorders
NGS Market in Metabolic/Immune Disorders by Purpose of Test
NGS Market in Metabolic/Immune Disorders by Test Complexity
Clinical NGS Market in Neurology
NGS Market in Neurology by Test Purpose
NGS Market in Neurology by Test Complexity
Clinical NGS Market in Reproductive Health
Reproductive Health Market by Test Application
NGS Market in Reproductive Health by Purpose of Test
NGS Market in Reproductive Health by Test Complexity
Clinical NGS Market in Microbiology and Infectious Diseases
NGS Market in Microbiology and Infectious Diseases by Purpose of Test
NGS Market in Microbiology and Infectious Diseases by Test Complexity
Clinical NGS Market in Transplantation
NGS Market in Transplantation by Organ Type
NGS Market in Transplantation by Purpose of Test
NGS Market in Transplantation by Test Complexity
Clinical NGS Market by Region
Global Market for NGS in Oncology by Region
Global Market for NGS in Reproductive Health by Region
Global Market for NGS in Transplantation by Region
Chapter 11 Patent Review
Patents on Circulating Tumor Cells
Patents on Exosomes
Patents on Cell-Free DNA
Patents Related to Biomarkers
Patent Considerations for the Use of Artificial Intelligence in Cancer Diagnostics
Liquid Biopsy Patent Litigation
Chapter 12 Company Profiles
Competitive Landscape
Top 5 Companies
AGILENT TECHNOLOGIES INC.
BGI GENOMICS CO. LTD
ILLUMINA INC.
QIAGEN
THERMO FISHER SCIENTIFIC INC.
Other Companies
ACCURAGEN HOLDINGS
ADAPTIVE BIOTECHNOLOGIES
ALCEN
AMBRY GENETICS
AMOY DIAGNOSTICS CO. LTD.
ANGLE PLC
APOSTLE SCIENCES
ARCEDI BIOTECH APS
ARMONICA TECHNOLOGIES INC.
ARUP LABORATORIES
ASURAGEN INC.
BAYLOR GENETICS
BECTON, DICKINSON AND CO.
BERRY GENOMICS BEIJING
BIOCAPTIVA LTD.
BIOCEPT INC.
BIODESIX
BIOFLUIDICA
BIOLIDICS LTD
BIOLOGICAL DYNAMICS
BIOMODAL
BIONANO GENOMICS
BIO-RAD LABORATORIES INC.
BIO-TECHNE
C2I GENOMICS
CAPIO BIOSCIENCES
CAREDX INC.
CARIS LIFE SCIENCE
CEGAT GMBH
CELL MICROSYSTEMS
CENTRILLION GENOMICS TECHNOLOGIES
CLARET BIOSCIENCE
CLEAR NOTE HEALTH
CLINICAL GENOMICS TECHNOLOGIES
CYCLOMICS
CYGNUS BIOSCIENCES CO. LTD.
DANAHER
DANTE LABS
DATAR CANCER GENETICS LTD.
DELFI DIAGNOSTICS
DIACARTA
DIAGNOLOGIX LLC
DIAGNOMICS INC.
DIAMIR BIO
DNALYTICS
DNANEXUS INC.
EARLYDIAGNOSTICS
EONE-DIAGNOMICS GENOME CENTER CO. LTD.
EPIC SCIENCES
EPIGENOMICS AG
EUROFINS GENOMICS
EVERLY HEALTH INC.
EXACT SCIENCES CORP.
EXOPERT
EXOSOMICS INC.
EZLIFE BIO
FABRIC GENOMICS INC.
F. HOFFMANN-LA ROCHE LTD
FLUXION BIOSCIENCES INC.
FREENOME HOLDINGS INC.
FULGENT GENETICS
FULL GENOMES CORP.
GENE BY GENE LTD.
GENEDX LLC
GENESEQ BIOSCIENCES
GENOMONCOLOGY LLC
GENOSABER
GRAIL INC.
GUARDANT HEALTH
HELIO GENOMICS
HELIX INC.
HTG MOLECULAR DIAGNOSTICS INC.
IMAGIA CANEXIA HEALTH
INCELLDX INC.
INEX INNOVATE PRIVATE LTD
INOVIQ
INTERPACE BIOSCIENCES INC.
INVITAE CORP.
INVIVOSCRIBE INC.
JABREHOO MED TECH CO. LTD.
JBS SCIENCE
JUMPCODE GENOMICS INC.
KONINKLIJKE PHILIPS N.V.
LABGENOMICS CO. LTD.
LABORATORY CORPORATION OF AMERICA HOLDINGS
LIQUID BIOPSY LABS
LUCENCE HEALTH INC.
LUNGLIFE AI INC.
MACROGEN INC.
MAPMYGENOME
MDXHEALTH INC.
MEDGENOME
MEDICOVER GENETICS
MENARINI SILICON BIOSYSTEMS SPA
MERCK KGAA
MICAREO RARE CELL DIAGNOSTICS
MICRONOMA INC.
MIR SCIENTIFIC
MUTANTDX
MYRIAD GENETICS INC.
NANOSTRING TECHNOLOGIES INC.
NATERA INC.
NEBULA GENOMICS
NEOGENOMICS LABORATORIES
NEW ENGLAND BIOLABS
NEW HORIZON HEALTH LTD.
NOVIGENIX SA
NOVOGENE CO. LTD.
NRICHDX INC.
NUPROBE INC.
NX PRENATAL INC.
ONCIMMUNE HOLDINGS PLC
ONCOCYTE CORP.
ONCODNA
OPKO HEALTH
ORCHID
OXFORD NANOPORE TECHNOLOGIES LTD.
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PANGAEA ONCOLOGY
PERSONAL GENOME DIAGNOSTICS INC.
PERSONALIS INC.
PHASE SCIENTIFIC
PIERIANDX
PREDICINE
PRENETICS GROUP
QCDX LLC
QUANTAPORE
QUANTGENE INC.
QUANTUMDX
QUEST DIAGNOSTICS
RARECELLS INC.
RAVGEN
REAL TIME GENOMICS
RESOLUTION BIOSCIENCE INC.
SAGA DIAGNOSTICS AB
SANO GENETICS
SCREENCELL
SEEKIN INC.
SEQUENCING.COM
SEVEN BRIDGES GENOMICS INC.
SINGLE TECHNOLOGIES
SMARTCATCH
STAGEZERO LIFE SCIENCES. LTD.
STRAND
STRATA ONCOLOGY
SYAPSE INC.
SYSMEX INOSTICS GMBH
TAKARA BIO INC.
TELEXOS GMBH
TWINSTRAND BIOSCIENCES INC.
TWIST BIOSCIENCE
UNCHAINED LABS
UNIVERSAL DX
VELA DIAGNOSTICS
VERACYTE
VOLITIONRX
VORTEX BIOSCIENCES
YOURGENE HEALTH
YIKON GENOMICS CO. LTD.

 

ページTOPに戻る


 

Summary

Report Scope:

The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents, and companies. The markets for NGS-based diagnostics are given for the years 2020, 2021, 2022, 2023 and 2028.

This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing. It then discusses some of the significant research initiatives that impact clinical NGS applications. Liquid biopsy formats are discussed. The main market driving forces are also discussed.

The report examines the markets by test complexity, clinical indication and test purpose. Test complexity refers to the plex level (i.e., the number of genetic markers that can be analyzed within a sample) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics, etc.) will be in demand in the future.

The report provides market data and forecasts for NGS diagnostics by specific applications, including those for oncology, cardiovascular diseases, clinical microbiology/infectious diseases, Mendelian disorders, metabolic/immune disorders, neurological disorders, reproductive health, and transplant medicine.

Specific geographic markets are discussed, namely North America, Europe, Asia-Pacific, and the Rest of the World.

Industry sectors analyzed include DNA sequencing instruments; long-read sequencing; sequencing informatics; target enrichment; CTC capture and detection; liquid biopsy; cancer screening/early detection; direct-to-consumer testing; and noninvasive prenatal testing.

More than 100 companies in the clinical NGS industry are profiled in this report.

BCC Research also provides a summary of the recent, primary industry acquisitions and strategic alliances, including key alliance trends.

Report Includes:

- 41 data tables and 237 additional tables
- An overview of the global market for emerging clinical applications of next-generation sequencing
- Analysis of global market trends, featuring historical revenue data for 2020 to 2022, estimates for 2023, as well as forecasts for 2028, including projections of compound annual growth rates (CAGRs) through 2028
- Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by disease indication, test complexity, test purpose, application and geographic region
- Discussion of market opportunities for clinical NGS products, clinical applications, industry structure, regulatory scenarios and use of NGS-based diagnostics and technologies
- Coverage of genome mapping programs, technological advances and innovations in NGS platforms, and the Ion Torrent Genexus System from Thermo Fisher Scientific and the Magnis NGS Prep System lfrom Agilent Technologies Inc
- Description of NGS-oriented tests such as non-invasive prenatal testing (NIPT) and pre-implantation genetic testing (PGT), and a discussion of their advantages
- Market share analysis of the key companies and a look at their proprietary technologies, strategic alliances and other key market strategies, plus a patent analysis
- Profiles of the leading players, including Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Agilent Technologies Inc., and BGI Genomics



ページTOPに戻る


Table of Contents

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
What’s New in This Report?
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Overview
Introduction
Liquid and Tissue Biopsy
Clinical NGS Market
Growth Drivers of Clinical NGS
Key Trends
Industry
Chapter 4 Technology Background
Importance of DNA
Genetic Variation and Analysis
Genetic Analysis Technologies
Sequencing in Clinical Applications
Sequencing Technologies
History of DNA Sequencing
Sanger Sequencing Technology
NGS Platforms
Short-Read Platforms
Long-Read Platforms
Informatics Technologies
Base Calling
Mapping to a Reference Sequence
Variant Analysis
Artificial Intelligence Technologies
Clinical Sequencing Technology Challenges
Chapter 5 Clinical NGS Initiatives and Emerging Technologies
R&D Initiatives and Programs
1+ Million Genomes
Access to Treatment and Testing (ACTT)
Access to Comprehensive Genomic Profiling Coalition (ACGP)
Africa Pathogen Genomics Initiative
Blood Profiling Atlas
Cancer-ID
Cancer Moon Shots Program
China Precision Medicine Initiative
ClinGen
CTC Trap Consortium
diaRNAgnosis Project
Early Cancer Detection Consortium
EpiFemCare
France Genomic Medicine Plan
Friends of Cancer Research Project
Genomic Medicine Sweden
HCA-Organoid
Human Cell Atlas
Human Immunomics Initiative
Immunomonitor Consortium
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy Program
Intervene
Liquid Biopsies and Imaging for Improved Cancer Care
Liquid Biopsy-Based Malignant Tumor Early Screening Technology Research and Development Project
Liver Cancer Early Screening Comprehensive Prevention and Control Project
Lung Cancer Genomic Screening Project for Individualized Medicine in Asia
Million Veteran Program
Medical Genome Initiative
MedSeq
Precision Medicine Initiative
Prompt
QuIP Project
SPHERES
Target ALS Diagnosis Initiative
TopMed
Treehouse Childhood Cancer Initiative
Very Rare Cancer Consortium
Worldwide Innovative Networking (WIN) Consortium
Single-Cell Research
Cambridge Single-Cell Analysis Core Facility
Harvard Medical School Single-Cell Core
Mayo Medical Genome Facility
National Center for Single-Cell Biology
Next-Generation Single-Cell Analysis Program
Single-Cell Analysis Core
UC San Francisco Single-Cell Analysis Center
The Wistar Institute of Anatomy and Biology
Population Sequencing Projects
Chapter 6 Clinical NGS Applications
Introduction
Cancer Applications
Precision Medicine
Liquid Biopsy Biomarkers
Mendelian Disorders Applications
Reproductive Health Applications
Noninvasive Prenatal Testing
Newborn Screening
Microbiology and Infectious Disease Applications
Complex Disorders Applications
Chapter 7 Clinical NGS Industry
Sequencing Instrument Industry
Companies
Third-Generation Sequencing Industry
Sequencing Informatics Industry
Target Enrichment and Amplification Industry
CTC Capture and Detection Industry
Liquid Biopsy Assay Industry
Liquid Biopsy Cancer Screening/Early Detection Industry
Health-Focused DTC Genetic Testing Industry: Two Market Models
DTC Clinical Health Genetic Testing Industry
Noninvasive Prenatal Testing (NIPT) Industry
Chapter 8 ESG Development
Introduction to ESG
The Sustainability of NGS in Industry
Case Study
BCC Research Viewpoint
Chapter 9 Acquisitions and Strategic Alliances
Acquisitions
Strategic Alliances
Key Trends
Chapter 10 Clinical NGS Markets
Market Dynamics
Market Drivers
Impact of COVID-19 on the Clinical NGS Markets
Clinical NGS Market by Disease Category
Clinical NGS Market by Test Complexity
Clinical NGS Market by Purpose of Test
Clinical NGS Market in Oncology
Market by Indication in Oncology
NGS Market in Oncology by Purpose of Test
NGS Market in Oncology by Test Complexity
Clinical NGS Market in Cardiology
NGS Market in Cardiology by Purpose of Test
NGS Market in Cardiology by Test Complexity
Clinical NGS Market in Mendelian Disorders
NGS Market in Mendelian Disorders by Test Complexity
Clinical NGS Market in Metabolic/Immune Disorders
NGS Market in Metabolic/Immune Disorders by Purpose of Test
NGS Market in Metabolic/Immune Disorders by Test Complexity
Clinical NGS Market in Neurology
NGS Market in Neurology by Test Purpose
NGS Market in Neurology by Test Complexity
Clinical NGS Market in Reproductive Health
Reproductive Health Market by Test Application
NGS Market in Reproductive Health by Purpose of Test
NGS Market in Reproductive Health by Test Complexity
Clinical NGS Market in Microbiology and Infectious Diseases
NGS Market in Microbiology and Infectious Diseases by Purpose of Test
NGS Market in Microbiology and Infectious Diseases by Test Complexity
Clinical NGS Market in Transplantation
NGS Market in Transplantation by Organ Type
NGS Market in Transplantation by Purpose of Test
NGS Market in Transplantation by Test Complexity
Clinical NGS Market by Region
Global Market for NGS in Oncology by Region
Global Market for NGS in Reproductive Health by Region
Global Market for NGS in Transplantation by Region
Chapter 11 Patent Review
Patents on Circulating Tumor Cells
Patents on Exosomes
Patents on Cell-Free DNA
Patents Related to Biomarkers
Patent Considerations for the Use of Artificial Intelligence in Cancer Diagnostics
Liquid Biopsy Patent Litigation
Chapter 12 Company Profiles
Competitive Landscape
Top 5 Companies
AGILENT TECHNOLOGIES INC.
BGI GENOMICS CO. LTD
ILLUMINA INC.
QIAGEN
THERMO FISHER SCIENTIFIC INC.
Other Companies
ACCURAGEN HOLDINGS
ADAPTIVE BIOTECHNOLOGIES
ALCEN
AMBRY GENETICS
AMOY DIAGNOSTICS CO. LTD.
ANGLE PLC
APOSTLE SCIENCES
ARCEDI BIOTECH APS
ARMONICA TECHNOLOGIES INC.
ARUP LABORATORIES
ASURAGEN INC.
BAYLOR GENETICS
BECTON, DICKINSON AND CO.
BERRY GENOMICS BEIJING
BIOCAPTIVA LTD.
BIOCEPT INC.
BIODESIX
BIOFLUIDICA
BIOLIDICS LTD
BIOLOGICAL DYNAMICS
BIOMODAL
BIONANO GENOMICS
BIO-RAD LABORATORIES INC.
BIO-TECHNE
C2I GENOMICS
CAPIO BIOSCIENCES
CAREDX INC.
CARIS LIFE SCIENCE
CEGAT GMBH
CELL MICROSYSTEMS
CENTRILLION GENOMICS TECHNOLOGIES
CLARET BIOSCIENCE
CLEAR NOTE HEALTH
CLINICAL GENOMICS TECHNOLOGIES
CYCLOMICS
CYGNUS BIOSCIENCES CO. LTD.
DANAHER
DANTE LABS
DATAR CANCER GENETICS LTD.
DELFI DIAGNOSTICS
DIACARTA
DIAGNOLOGIX LLC
DIAGNOMICS INC.
DIAMIR BIO
DNALYTICS
DNANEXUS INC.
EARLYDIAGNOSTICS
EONE-DIAGNOMICS GENOME CENTER CO. LTD.
EPIC SCIENCES
EPIGENOMICS AG
EUROFINS GENOMICS
EVERLY HEALTH INC.
EXACT SCIENCES CORP.
EXOPERT
EXOSOMICS INC.
EZLIFE BIO
FABRIC GENOMICS INC.
F. HOFFMANN-LA ROCHE LTD
FLUXION BIOSCIENCES INC.
FREENOME HOLDINGS INC.
FULGENT GENETICS
FULL GENOMES CORP.
GENE BY GENE LTD.
GENEDX LLC
GENESEQ BIOSCIENCES
GENOMONCOLOGY LLC
GENOSABER
GRAIL INC.
GUARDANT HEALTH
HELIO GENOMICS
HELIX INC.
HTG MOLECULAR DIAGNOSTICS INC.
IMAGIA CANEXIA HEALTH
INCELLDX INC.
INEX INNOVATE PRIVATE LTD
INOVIQ
INTERPACE BIOSCIENCES INC.
INVITAE CORP.
INVIVOSCRIBE INC.
JABREHOO MED TECH CO. LTD.
JBS SCIENCE
JUMPCODE GENOMICS INC.
KONINKLIJKE PHILIPS N.V.
LABGENOMICS CO. LTD.
LABORATORY CORPORATION OF AMERICA HOLDINGS
LIQUID BIOPSY LABS
LUCENCE HEALTH INC.
LUNGLIFE AI INC.
MACROGEN INC.
MAPMYGENOME
MDXHEALTH INC.
MEDGENOME
MEDICOVER GENETICS
MENARINI SILICON BIOSYSTEMS SPA
MERCK KGAA
MICAREO RARE CELL DIAGNOSTICS
MICRONOMA INC.
MIR SCIENTIFIC
MUTANTDX
MYRIAD GENETICS INC.
NANOSTRING TECHNOLOGIES INC.
NATERA INC.
NEBULA GENOMICS
NEOGENOMICS LABORATORIES
NEW ENGLAND BIOLABS
NEW HORIZON HEALTH LTD.
NOVIGENIX SA
NOVOGENE CO. LTD.
NRICHDX INC.
NUPROBE INC.
NX PRENATAL INC.
ONCIMMUNE HOLDINGS PLC
ONCOCYTE CORP.
ONCODNA
OPKO HEALTH
ORCHID
OXFORD NANOPORE TECHNOLOGIES LTD.
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PANGAEA ONCOLOGY
PERSONAL GENOME DIAGNOSTICS INC.
PERSONALIS INC.
PHASE SCIENTIFIC
PIERIANDX
PREDICINE
PRENETICS GROUP
QCDX LLC
QUANTAPORE
QUANTGENE INC.
QUANTUMDX
QUEST DIAGNOSTICS
RARECELLS INC.
RAVGEN
REAL TIME GENOMICS
RESOLUTION BIOSCIENCE INC.
SAGA DIAGNOSTICS AB
SANO GENETICS
SCREENCELL
SEEKIN INC.
SEQUENCING.COM
SEVEN BRIDGES GENOMICS INC.
SINGLE TECHNOLOGIES
SMARTCATCH
STAGEZERO LIFE SCIENCES. LTD.
STRAND
STRATA ONCOLOGY
SYAPSE INC.
SYSMEX INOSTICS GMBH
TAKARA BIO INC.
TELEXOS GMBH
TWINSTRAND BIOSCIENCES INC.
TWIST BIOSCIENCE
UNCHAINED LABS
UNIVERSAL DX
VELA DIAGNOSTICS
VERACYTE
VOLITIONRX
VORTEX BIOSCIENCES
YOURGENE HEALTH
YIKON GENOMICS CO. LTD.

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


BCC Research社はどのような調査会社ですか?


BCCリサーチ(BCC Research)は1971年に設立され、様々な業界経験を持つアナリストと編集者によりトップクラスの市場情報源を長年提供している調査会社です。   設立初期は先端材料とプラ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る